Prostate Cancer in a Changing Landscape- PSA, PCN DES and diagnostic pathway transformation
13 Oct 2022
Best Practice Workshop Theatre
The 2022/23 Primary Care Network DES marks a significant shift in NHS practice around prostate cancer and the prostate cancer diagnostic pathway is changing. Better technologies such as mpMRI scans can rule out 25% of men from needing a biopsy.
- This session will explore the PSA test, PCN DES, changes in the prostate cancer diagnostic pathway, and more to provide a valuable update to Primary Care clinicians.